Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 12, 2026
AMAT vs LRCX: Semiconductor Equipment Leaders Delivering +78% and +75% Year-to-Date Gains

AMAT vs LRCX: Semiconductor Equipment Leaders Delivering +78% and +75% Year-to-Date Gains

Key Takeaways

  • Both AMAT and LRCX are leading providers of semiconductor manufacturing equipment, with exposure to artificial intelligence-driven demand for advanced chips.
  • In recent market activity, both stocks experienced strong gains earlier in 2026 followed by pullbacks, with AMAT showing a year-to-date return of approximately 78% and LRCX around 75% as of mid-September 2026.
  • AMAT maintains a broader business portfolio spanning deposition, etch, and inspection tools, while LRCX focuses more narrowly on etch and deposition processes critical for memory and logic chips.
  • Valuation metrics indicate AMAT trades at a lower trailing price-to-earnings ratio compared to LRCX, reflecting differences in earnings profiles and growth expectations.
  • Sector sentiment remains tied to wafer fabrication equipment spending, with both companies benefiting from capacity expansions but facing risks from cyclical industry dynamics and geopolitical factors.
  • Relative performance in the past month shows both stocks declining from June 2026 peaks, highlighting shared sensitivity to broader technology sector movements.

Setting the Stage for Two Industry Heavyweights

Applied Materials (AMAT) and Lam Research (LRCX) stand out as two of the largest players in the semiconductor equipment space. This comparison looks at their business models, recent stock moves, and how they fit into the ongoing need for advanced manufacturing tools. It offers useful context for traders and investors examining performance differences between these closely linked yet distinct providers of semiconductor capital equipment.

AMAT’s Business and Market Moves

Applied Materials supplies equipment, services, and software for semiconductor, display, and related industries. Its offerings cover deposition, etch, ion implantation, and inspection technologies used in chip production. Shares climbed sharply through the first half of 2026 on artificial intelligence-related spending before pulling back from June highs near $740 to around $456 by mid-September. Year-to-date returns reached about 78%, with trailing twelve-month gains near 170%. Recent weeks aligned with broader sector consolidation, leaving the stock below its 52-week high yet above longer-term averages. Analyst price targets average around $641, supported by earnings growth tied to advanced node demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

LRCX’s Focus and Price Action

Lam Research specializes in wafer fabrication equipment, especially etch and deposition systems needed for advanced logic and memory chips. It has benefited from the same industry expansion. Shares moved higher earlier in 2026 before retreating from peaks near $438 to roughly $298 by mid-September. Year-to-date performance came in near 75%, with one-year returns around 159%. Recent weeks reflected industry-wide adjustments after elevated valuations, though the stock stayed well above prior-year averages. Sentiment has been shaped by upward revisions to wafer fabrication equipment spending forecasts and supply-chain capacity constraints.

Side-by-Side Analysis

AMAT brings greater diversification across semiconductor and display segments, which can support steadier revenue compared with LRCX’s narrower emphasis on etch and deposition for memory uses. Both companies draw growth from artificial intelligence infrastructure spending, though LRCX may feel more impact from memory-cycle swings. Recent momentum has been similar, with both posting solid year-to-date gains before shared pullbacks. Key risks include industry cyclicality, supply-chain issues, and regulatory pressures on global chip production. Market views remain optimistic on long-term demand while showing caution after earlier 2026 valuations. AMAT generally trades at a lower price-to-earnings multiple, creating a valuation contrast with LRCX’s premium stance.

AI Model Perspective on the Pair

Looking at relative year-to-date consistency, earnings growth paths, and sector positioning, Tickeron’s AI models currently give a modestly higher probabilistic preference to AMAT. The view factors in trend stability and broader portfolio exposure that could add resilience during sector swings, though results depend on changing market conditions and individual risk tolerance.

Exploring Tickeron’s Trending AI Robots

In my own research process, I often turn to Tickeron’s Trending AI Robots page to review high-performing automated trading systems across thousands of tickers. It highlights bots that have shown suitability for current conditions, consistent strategies, and solid statistics, helping me cross-check ideas alongside fundamental analysis without replacing my own judgment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMAT, LRCX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AMAT's RSI Oscillator recovers from oversold territory

The RSI Indicator for AMAT moved out of oversold territory on September 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 24 of the 28 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 55 cases where AMAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for AMAT just turned positive on September 09, 2026. Looking at past instances where AMAT's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.

Following a +8.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMAT advanced for three days, in 253 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMAT as a result. In 62 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

The Aroon Indicator for AMAT entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 25 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. AMAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock slightly better than average.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.144) is normal, around the industry mean (7.734). P/E Ratio (39.387) is within average values for comparable stocks, (150.023). Projected Growth (PEG Ratio) (0.907) is also within normal values, averaging (1.100). Dividend Yield (0.004) settles around the average of (0.006) among similar stocks. P/S Ratio (11.834) is also within normal values, averaging (29.849).

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 61.11B. The market cap for tickers in the group ranges from 555.66K to 659.24B. ASML holds the highest valuation in this group at 659.24B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 2%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was 25%. COHU experienced the highest price growth at 13%, while DQ experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 34
Price Growth Rating: 51
SMR Rating: 71
Profit Risk Rating: 63
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
AMAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of equipment and software for the semiconductor industries

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
3050 Bowers Avenue
Phone
+1 408 727-5555
Employees
36500
Web
https://www.appliedmaterials.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.